Literature DB >> 15579256

Alveolar macrophages in chronic obstructive pulmonary disease (COPD).

P J Barnes1.   

Abstract

Alveolar macrophages play a critical role as orchestrators of inflammation in chronic obstructive pulmonary disease (COPD). The numbers of alveolar macrophages are markedly increased in the lungs of patients with COPD as a result of increased recruitment, proliferation and survival. Alveolar macrophages secrete many inflammatory mediators, oxidants, proteins and proteinases in response to cigarette smoke extract and other stimuli. In COPD there is amplified secretion of these inflammatory products which may be related to defective histone deacetylase-2, which may also account for the steroid resistance of these cells in COPD patients. There are several novel therapeutic strategies targeted at macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579256

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  23 in total

1.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

2.  The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung.

Authors:  Robert Foronjy; Jeanine D'Armiento
Journal:  Clin Appl Immunol Rev       Date:  2006-01-01

3.  Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers.

Authors:  Angeliki Kazeros; Ben-Gary Harvey; Brendan J Carolan; Holly Vanni; Anja Krause; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

4.  Induction of pulmonary antibodies against oxidized lipids in mice exposed to cigarette smoke.

Authors:  Danya Thayaparan; Pamela Shen; Martin R Stämpfli; Mathieu C Morissette
Journal:  Respir Res       Date:  2016-08-04

5.  Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.

Authors:  Amel Ben Anes; Hela Ben Nasr; Abdelhamid Garrouch; Sarra Bennour; Sarra Bchir; Mohamed Hachana; Mohamed Benzarti; Zouhair Tabka; Karim Chahed
Journal:  Mol Cell Biochem       Date:  2017-12-12       Impact factor: 3.396

6.  Myeloid-specific Fos-related antigen-1 regulates cigarette smoke-induced lung inflammation, not emphysema, in mice.

Authors:  Michelle Vaz; Subbiah Rajasekaran; Haranatha R Potteti; Sekhar P Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 7.  Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know.

Authors:  Mathieu C Morissette; Julie Parent; Julie Milot
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

8.  Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages.

Authors:  Jessica Hoppstädter; Britta Diesel; Robert Zarbock; Tanja Breinig; Dominik Monz; Marcus Koch; Andreas Meyerhans; Ludwig Gortner; Claus-Michael Lehr; Hanno Huwer; Alexandra K Kiemer
Journal:  Respir Res       Date:  2010-09-15

9.  Critical role of aldehydes in cigarette smoke-induced acute airway inflammation.

Authors:  Marco van der Toorn; Dirk-Jan Slebos; Harold G de Bruin; Renee Gras; Delaram Rezayat; Lucie Jorge; Koen Sandra; Antoon J M van Oosterhout
Journal:  Respir Res       Date:  2013-04-17

10.  Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease.

Authors:  R Sharan; M Perez-Cruz; G Kervoaze; Pierre Gosset; V Weynants; F Godfroid; P Hermand; F Trottein; M Pichavant; P Gosset
Journal:  Mucosal Immunol       Date:  2016-05-04       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.